DUBLIN, Nov. 6, 2019 /PRNewswire/ -- November 6, 2019 – Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will participate in a corporate presentation at the 28th Annual Credit Suisse Healthcare Conference on Tuesday, November 12, 2019, at 3:00 p.m. MT. The conference will take

NEWARK, Calif., Nov. 6, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the third quarter ended September 30, 2019, and provided a corporate update.

BAD HOMBURG, Germany, Nov. 6, 2019 /PRNewswire/ -- Fresenius SE & Co. KGaA (Frankfurt stock exchange : FRE, US ADR program : FSNUY) based in Bad Homburg, Germany, and focused on global healthcare products and services for dialysis, hospitals and outpatient medical care, today announced that Markus Geo

LAS VEGAS, Nov. 6, 2019 /PRNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas.

PHILADELPHIA, Nov. 6, 2019 /PRNewswire/ --   Financial and Business Highlights:Net Sales, Profitability Exceeded Expectations Launched First-to-Market Posaconazole Expanded Pipeline with Significant Future Opportunities:      • Lev

IRVINE, Calif., Nov. 6, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: PEAK) announced today that it has priced a public offering of $750 million aggregate principal amount of 3.000% senior unsecured notes due 2030. The price to investors was 99.640% of the principal amount of the notes. Healthpeak intends to u

REDWOOD CITY, Calif., Nov. 6, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported financial results for the third quarter ended September 30, 2019. Revenue for the third quarter of 2019 was

SAN CARLOS, Calif., Nov. 6, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial res

SAN RAFAEL, Calif., Nov. 6, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an R&D Day at 8:00am ET on Thursday, November 14, 2019. BioMarin management and external experts will provide an update to the investment community on the Company's development portfolio, which is focused on innovative therapies to trea

FREMONT, Calif., Nov. 6, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced a late-breaking oral presentation of its recently announced AMPLIFY Phase 3 clinical data will be presented at Kidney Week 2019, t